Immunogenicity of meningococcal ACYW135 polysaccharide vaccine in Saudi children 5 to 9 years of age

被引：13
|
作者：
Khalil, M
Al-Mazrou, Y
Balmer, P [1 ]
Bramwell, J
Andrews, N
Borrow, R
机构：
[1] Manchester Royal Infirm, HPA North West Lab, Meningococcal Reference Unit, Manchester M13 9WZ, Lancs, England
[2] King Fahad Specialist Hosp, Med Educ & Res Ctr, Qasim, Saudi Arabia
[3] Minist Hlth, Dept Prevent Med, Riyadh, Saudi Arabia
[4] HPA Ctr Infect, Stat Unit, London NW9 5EQ, England
来源：
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY | 2005年 / 12卷 / 10期
关键词：
D O I：
10.1128/CDLI.12.10.1251-1253.2005
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Meningococcal tetravalent polysaccharide vaccines were observed to be immunogenic in Saudi children 5 to 9 years of age, with > 90% having serum bactericidal antibody titers of >= 8 for serogroups A, Y, and W135; for serogroup C, 77% were putatively protected after vaccination.
引用
收藏
页码：1251 / 1253
页数：3
相关论文
共 50 条
  • [41] Evaluation of a New Vi Polysaccharide Typhoid Vaccine in Children Aged 2-5 Years
    Leticia Cordero-Yap
    Religaya G. Rivera
    Alberto P. Dispo
    Julietta Mallabo
    BioDrugs, 2001, 15 : 27 - 27
  • [42] Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5-49 years of age
    Block, Stan L.
    Yogev, Ram
    Hayden, Frederick G.
    Ambrose, Christopher S.
    Zeng, Wen
    Walker, Robert E.
    VACCINE, 2008, 26 (38) : 4940 - 4946
  • [43] Immunogenicity and Safety of a Meningococcal Quadrivalent Conjugate Vaccine in Saudi Arabian Adolescents Previously Vaccinated with One Dose of Bivalent and Quadrivalent Meningococcal Polysaccharide Vaccines: a Phase III, Controlled, Randomized, and Modified Blind-Observer Study
    Al-Mazrou, Yagob
    Khalil, Mohamed
    Findlow, Helen
    Chadha, Helen
    Castells, Valerie Bosch
    Johnson, David R.
    Borrow, Ray
    CLINICAL AND VACCINE IMMUNOLOGY, 2012, 19 (07) : 999 - 1004
  • [44] Immunogenicity of the Trivalent Inactivated Influenza Vaccine in Young Children Less than 4 Years of Age, with a Focus on Age and Baseline Antibodies
    Mugitani, Ayumi
    Ito, Kazuya
    Irie, Shin
    Eto, Takashi
    Ishibashi, Motoki
    Ohfuji, Satoko
    Fukushima, Wakaba
    Maeda, Akiko
    Hirota, Yoshio
    CLINICAL AND VACCINE IMMUNOLOGY, 2014, 21 (09) : 1253 - 1260
  • [45] Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal ACWY Tetanus Toxoid Conjugate Vaccine in Healthy Adolescents and Young Adults 10 to 25 Years of Age
    Baxter, Roger
    Baine, Yaela
    Ensor, Kathleen
    Bianco, Veronique
    Friedland, Leonard R.
    Miller, Jacqueline M.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2011, 30 (03) : E41 - E48
  • [46] Immunogenicity and Safety of a Recombinant Tetravalent Dengue Vaccine in Children and Adolescents Ages 9-16 Years in Brazil
    Dayan, Gustavo H.
    Garbes, Pedro
    Noriega, Fernando
    Izoton de Sadovsky, Ana Daniela
    Rodrigues, Patricia Marques
    Giuberti, Camila
    Dietze, Reynaldo
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2013, 89 (06): : 1058 - 1065
  • [47] Safety and Immunogenicity of Tetanus-Diphtheria-Acellular Pertussis Vaccine Administered to Children 10 or 11 Years of Age
    Marshall, Gary S.
    Pool, Vitali
    Greenberg, David P.
    Johnson, David R.
    Sheng, Xiaohua
    Decker, Michael D.
    CLINICAL AND VACCINE IMMUNOLOGY, 2014, 21 (11) : 1560 - 1564
  • [48] Immunogenicity and safety of MenACWY-TT, a quadrivalent meningococcal tetanus toxoid conjugate vaccine recently licensed in the United States for individuals ≥2 years of age
    Marshall, Gary S.
    Pelton, Stephen, I
    Robertson, Corwin A.
    Oster, Philipp
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (06)
  • [49] Antibody persistence up to 5 years after vaccination of toddlers and children between 12 months and 10 years of age with a quadrivalent meningococcal ACWY-tetanus toxoid conjugate vaccine
    Vesikari, Timo
    Forsten, Aino
    Bianco, Veronique
    Van der Wielen, Marie
    Miller, Jacqueline M.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2016, 12 (01) : 132 - 139
  • [50] Epidemiology of invasive pneumococcal disease in Saudi Arabian children younger than 5 years of age
    Almazrou Y.
    Shibl A.M.
    Alkhlaif R.
    Pirçon J.-Y.
    Anis S.
    Kandeil W.
    Hausdorff W.P.
    Journal of Epidemiology and Global Health, 2016, 6 (2) : 95 - 104
12345